IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 194 filers reported holding IVERIC BIO INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $36,981,600 | +15.2% | 1,520,000 | +1.3% | 5.29% | +40.7% |
| Q4 2022 | $32,115,000 | +19.3% | 1,500,000 | 0.0% | 3.76% | +13.7% |
| Q3 2022 | $26,910,000 | -11.2% | 1,500,000 | -16.7% | 3.31% | -15.8% |
| Q1 2022 | $30,294,000 | +39.4% | 1,800,000 | +38.5% | 3.93% | +75.2% |
| Q4 2021 | $21,736,000 | +37.8% | 1,300,000 | -48.0% | 2.24% | +69.1% |
| Q2 2021 | $15,775,000 | +112.7% | 2,500,000 | +108.3% | 1.33% | +83.1% |
| Q1 2021 | $7,416,000 | +61.6% | 1,200,000 | +33.3% | 0.72% | -21.0% |
| Q2 2020 | $4,590,000 | +2.2% | 900,000 | +71.9% | 0.92% | -17.2% |
| Q4 2019 | $4,491,000 | – | 523,462 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,729,041 | $10,685,000 | 4.26% |
| Soleus Capital Management, L.P. | 3,380,979 | $20,894,000 | 3.76% |
| ACUTA CAPITAL PARTNERS, LLC | 1,579,093 | $9,759,000 | 3.52% |
| Stonepine Capital Management, LLC | 875,180 | $5,409,000 | 2.92% |
| Samsara BioCapital, LLC | 2,372,476 | $14,664,000 | 2.70% |
| Ghost Tree Capital, LLC | 1,125,000 | $6,953,000 | 1.63% |
| Octagon Capital Advisors LP | 680,036 | $4,203,000 | 1.58% |
| Altium Capital Management LP | 902,633 | $5,578,000 | 1.55% |
| Vivo Capital, LLC | 5,966,527 | $36,873,000 | 1.30% |
| FRAZIER MANAGEMENT LLC | 2,544,500 | $15,725,000 | 1.26% |